Peposertib is a potent, selective and orally bioavailable DNA-PK inhibitor, which, in both preclinical models and clinical trials, strongly potentiates the anti-tumor effects of ionizing radiation and DNA DSB-inducing agents, including anthracyclines [8,9,10]. This evidence concerns the gene PRKDC and neoplasm.